Volume 14 Issue 12, December 2000

Kinases: positive and negative regulators of apoptosis

• RA Franklin
• JA McCubrey

Dissecting the pathways to death

• PT Daniel

Expression and activity of caspases 1 and 3 in myelodysplastic syndromes

• D Boudard
• O Sordet
• L Campos

Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies

• A Mengarelli
• AP Iori
• W Arcese

Prognosis of patients with a second relapse of acute myeloid leukemia

• B Stoiser
• P Knöbl
• U Jaeger

Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α

• M Michallet
• A Thiébaut
• D Fière

Protean clinical manifestations in children with leukemias containing MLL-AF10 fusion

• L Gore
• J Ess
• SP Hunger

Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies

• SW Van Gool
• E Van Kerschaver
• H Vanderstichele

Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes

• E Solary
• L Mannone
• P Genne

Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells

• FE Bertrand
• CE Eckfeldt
• TW LeBien

Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification

• B Lemmers
• C Arnoulet
• C Schiff

A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide

• A Arcangeli
• L Fontana
• M Olivotto

Modifications in phospholipase D activity and isoform expression occur upon maturation and differentiation in vivo and in vitro in human myeloid cells

• MEl Marjou
• V Montalescot
• B Geny

Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31

• H Xie
• Z Hu
• CA Westbrook

Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML)

• Y Guan
• DE Hogge

Genetic instability is associated with histological transformation of follicle center lymphoma

• M Nagy
• M Balázs
• A Matolcsy

Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line

• M Irisarri
• J Plumas
• A Lajmanovich

A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

• C Dumontet
• C Thieblemont
• B Coiffier

mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method

• MG Rots
• JC Willey
• GJ Peters

Detection of hTERT protein by flow cytometry

• ASM Ali
• R Chopra
• NG Testa

Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro

• K Tarte
• G Fiol
• B Klein

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

• M Schrappe
• B Camitta
• C-H Pui

Note from the Editor

• N Muller-Bérat MD

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995

• V Conter
• M Aricò
• G Masera

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995

• M Schrappe
• A Reiter
• H Riehm

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995

• PS Gaynon
• ME Trigg
• WA Bleyer

Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92

• DO Harms
• GE Janka-Schaub

Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991

• WA Kamps
• AJP Veerman
• A van der Does-van den Berg

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)

• LB Silverman
• L Declerck
• SE Sallan

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

• E Vilmer
• S Suciu
• J Otten

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation

• G Gustafsson
• K Schmiegelow
• UM Saarinen-Pihkala

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994

• KW Maloney
• JJ Shuster
• BA Camitta

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

• C-H Pui
• JM Boyett
• WE Evans

Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981–1995

• M Tsuchida
• K Ikuta
• S Nakazawa

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–1997

• OB Eden
• G Harrison
• BES Gibson

An unusual presentation of a case of T cell angiotropic (intravascular) lymphoma

• G Isimbaldi
• L Corral
• A Biondi

Intrathecal mitozantrone has to be prohibited

• JH Dalle
• A Lambilliotte
• B Nelken

Is there any genetic susceptibility to acute promyelocytic leukemia?

• X Thomas

Author Index

Keyword index